Patient characteristics at study entry
| Patient no. . | Age, y . | Histology . | Ann Arbor stage . | Years after diagnosis . | Prior treatment . | No. of relapses . |
|---|---|---|---|---|---|---|
| 1 | 45 | LPHD | IA | 17 | Radiation | 3 |
| 2 | 45 | LPHD | IIA | 9 | Radiation | 2 |
| 3 | 30 | LPHD | IVB | 6 | COPP/ABVD | 3 |
| 4 | 35 | LPHD | IA | 3 | Radiation | 1 |
| 5 | 49 | LPHD | IIA | 9 | COPP/ABVD, radiation | 2 |
| 6 | 41 | LPHD | IIB | 17 | Radiation | 1 |
| 7 | 51 | T-cell–rich B-NHL | IVA | 8 | COPP/ABVD, splenectomy | 1 |
| 8 | 47 | LPHD | IIIA | 8 | CHOP, VIP-E | 1 |
| 9 | 41 | LPHD | IA | 21 | MOPP, radiation, ABVD | 2 |
| 10 | 23 | LPHD | IVB | 0.5 | BEACOPP | 1 |
| 11 | 34 | T-cell–rich B-NHL | IVB | 6 | COPP/ABVD, radiation, AVD, VIP-E, ABMT | 3 |
| 12 | 18 | HD | IVA | 1.5 | OPPA, COPP, MINE-R | 1 |
| 13 | 37 | LPHD | IIB | 3 | Radiation | 1 |
| 14 | 51 | HD | IIB | 17 | MOPP, COPP/ABVD, ABVD, ABMT | 3 |
| Patient no. . | Age, y . | Histology . | Ann Arbor stage . | Years after diagnosis . | Prior treatment . | No. of relapses . |
|---|---|---|---|---|---|---|
| 1 | 45 | LPHD | IA | 17 | Radiation | 3 |
| 2 | 45 | LPHD | IIA | 9 | Radiation | 2 |
| 3 | 30 | LPHD | IVB | 6 | COPP/ABVD | 3 |
| 4 | 35 | LPHD | IA | 3 | Radiation | 1 |
| 5 | 49 | LPHD | IIA | 9 | COPP/ABVD, radiation | 2 |
| 6 | 41 | LPHD | IIB | 17 | Radiation | 1 |
| 7 | 51 | T-cell–rich B-NHL | IVA | 8 | COPP/ABVD, splenectomy | 1 |
| 8 | 47 | LPHD | IIIA | 8 | CHOP, VIP-E | 1 |
| 9 | 41 | LPHD | IA | 21 | MOPP, radiation, ABVD | 2 |
| 10 | 23 | LPHD | IVB | 0.5 | BEACOPP | 1 |
| 11 | 34 | T-cell–rich B-NHL | IVB | 6 | COPP/ABVD, radiation, AVD, VIP-E, ABMT | 3 |
| 12 | 18 | HD | IVA | 1.5 | OPPA, COPP, MINE-R | 1 |
| 13 | 37 | LPHD | IIB | 3 | Radiation | 1 |
| 14 | 51 | HD | IIB | 17 | MOPP, COPP/ABVD, ABVD, ABMT | 3 |
LPHD indicates lymphocyte-predominant Hodgkin disease; HD, Hodgkin disease; NHL, non-Hodgkin lymphoma; CHOP, cyclophosphamide, doxorubicin, prednisone, vincristine; COPP, cyclophosphamide, vincristine, procarbazine, prednisone; ABVD, doxorubicin, bleomycin, vinblastine, dacarbazine; OPPA, doxorubicin, procarbazine, prednisone, vincristine; BEACOPP, bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone; VIP-E, etoposide, ifosfamide, cisplatin, epirubicin; MOPP, mechlorethamine, vincristine, procarbazine, prednisone; and ABMT, autologous bone marrow transplantation.